Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Seed Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (41)
Prescription medicine registration (9)
Cancellation by sponsor (1)

Date

2026 (47)
2025 (1)
2024 (1)
2021 (2)

Search

Sponsor content

51 result(s) found, displaying 41 to 50

MSN-LINAGLIPTIN linagliptin 5 mg film-coated tablet blister pack (480446)

7 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-LINAGLIPTIN linagliptin 5 mg film-coated tablet blister pack.
LINAON linagliptin 5 mg film-coated tablet blister pack (480445)

7 April 2026

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LINAON linagliptin 5 mg film-coated tablet blister pack.
MSN-NILOTINIB (Seed Pharma Pty Ltd)

2 April 2026

Prescription medicine registration

Active ingredients: nilotinib hydrochloride sesquihydrate.
CADIBAN (Seed Pharma Pty Ltd)

25 February 2026

Prescription medicine registration

Active ingredients: apixaban.
TAPAL SR (Seed Pharma Pty Ltd)

12 February 2026

Prescription medicine registration

Active ingredients: tapentadol tartrate.
LINAON (Seed Pharma Pty Ltd)

22 January 2026

Prescription medicine registration

Active ingredients: linagliptin.
DAPAGLIFLOZIN VIATRIS (Seed Pharma Pty Ltd)

9 January 2026

Prescription medicine registration

Active ingredients: dapagliflozin.
POSAONE (Seed Pharma Pty Ltd)

20 November 2025

Prescription medicine registration

Active ingredients: posaconazole.
SEED PHARMA CARBIMAZOLE 5 carbimazole 5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2024

Cancellation by sponsor

Requested by Seed Pharma Pty Ltd
SP CARBIMAZOLE 5; SPPL CARBIMAZOLE 5; SEED PHARMA CARBIMAZOLE 20; SPPL CARBIMAZOLE 20; SP CARBIMAZOLE 20; WP CARBIMAZOLE 5; WP CARBIMAZOLE 20; SEED PHARMA CARBIMAZOLE 5 (Seed Pharma Pty Ltd)

17 September 2021

Prescription medicine registration

Active ingredients: carbimazole.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.